we had 20 patients with rheumatoid arthritis stop taking nsaias for two weeks and then take piroxicam , a new nsaia , for an additional ten weeks to assess the in vivo effects of nsaias on cellular immunity and rheumatoid factor levels .
C0003873
rheumatoid arthritis
C0031990
piroxicam